EMD-55790

Single-particle
3.11 Å
EMD-55790
3D View Gallery
Deposition: 21/11/2025
Map released: 22/07/2026
Last modified: 26/08/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-55790

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9tcc summary report (pdf.gz) Map-9tcc FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

African Horse Sickness Virus serotype 4 VP2 homotrimer

EMD-55790

Single-particle
3.11 Å
EMD-55790
3D View Gallery
Deposition: 21/11/2025
Map released: 22/07/2026
Last modified: 26/08/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: African horse sickness virus 4
Sample: VP2 homotrimer of African horse sickness virus 4.
Fitted models: 9tcc

Deposition Authors: Martinez-Castillo A, Aebischer A, Fu L, Breard E, Zientara S, Kortekaas J, Beer M, Abrescia NGA
Cryo-EM structure of African horse sickness virus VP2 receptor-binding protein enables nanoparticle vaccine design.
Martinez-Castillo A, Aebischer A, Toneatti P, Fu L, Vitour D, Sailleau C, Hoffmann B, Franzke K, Eschbaumer M, Weber S, Calvo Pinilla E, Ortego J, Gil-Carton D, Breard E, Zientara S, Kortekaas J, Beer M, Abrescia NG
(2026) Nat Commun , 17
PUBMED: 42401561
DOI: doi:10.1038/s41467-026-75067-9
ISSN: 2041-1723
Grant Support: